TX-SAFEGUARD-GLOBAL
27.1.2022 13:09:03 CET | Business Wire | Press release
Safeguard Global, a global future of work company, announced today its acquisition of Global Upside, a global expansion technology and services company based in San Jose, Calif. The deal expands the company’s ability to help emerging and established multinationals compliantly recruit, hire, pay—and now set up operations—anywhere in the world. The move also helps Safeguard Global continue building out its workforce management technology platform, Global Unity, to be able to provide end-to-end digital service.
The acquisition, part of an aggressive growth strategy, combines the momentum of the two hyper-growth companies in an industry that is growing quickly to meet increasing demand for workforce management solutions. It makes Safeguard Global, which founded the Employer of Record (EOR) industry in 2011, the largest EOR in global coverage and breadth of services. It also adds new markets in Latin America, Eastern Europe, Africa and Asia.
“The team at Global Upside built an amazing company with complementary solutions to ours,” says Bjorn Reynolds, Chief Executive Officer and founder of Safeguard Global. “Adding entity setup to our portfolio bridges a critical gap that allows us to partner with clients seamlessly as their business needs evolve. This makes us unique because we are the only company to offer clients the technology and resources to grow compliantly with one single partner. We help them hire workers of any classification in new markets, set up their own in-country entities to directly hire when the time is right, and centralize global payroll when operating in multiple markets around the world.”
Safeguard Global helps companies compete in a rapidly changing landscape. With market-leading employment and payroll solutions, Safeguard Global equips organizations with the technology, local market expertise and service to create opportunities that attract and retain the best talent and fuel their business growth.
“The future of work is about creating Work in Any Way experiences, which diversify not just where but how and when companies grow and people work,” Reynolds continues. “Safeguard Global’s solutions and technology enable flexibility in how companies expand their businesses and the types of work experiences they provide. That's a competitive advantage. Acquiring Global Upside provides us with more scale, support and capability to lead our clients and our industry through the future of work.”
About Safeguard Global
Safeguard Global is a future of work company that builds adaptive workforce management solutions for organizations seeking to thrive in the global economy. Safeguard Global enables success through smarter, more efficient global employee management, recruitment, payroll, onboarding, expense management and more, all powered by industry-leading data, technology, services and local market expertise. To learn more, visit www.safeguardglobal.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220126005640/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom